文献速递急性肾损伤慢性肾脏病

肾脏精准医学项目的基本原理与设计

Rationale and design of the Kidney Precision Medicine Project.
PubMed 文献 · Kidney Int · 2021-01-01

肾脏精准医学项目(KPMP)为多中心前瞻性队列研究,拟对CKD或AKI成人受试者进行方案化肾脏活检,结合传统与数字病理及转录组、蛋白组、代谢组分析和深度临床表型,构建开放可检索的肾脏组织图谱,并随访10年以明确临床结局,从而按分子特征、临床特征与结局对患者进行分层。

要点

  • KPMP对CKD或AKI成人行研究性肾脏活检,构建开放可检索的肾脏组织图谱。
  • 整合病理与多组学及深度临床表型,识别疾病亚组及新治疗靶点。
  • 受试者前瞻随访10年以明确临床结局。

核心结论

  • 对CKD和AKI患者进行机制性刻画,有望推动其预防、诊断和治疗的精准医学路径。

研究设计与样本

  • 多中心前瞻性队列研究,纳入接受研究性方案肾脏活检的CKD或AKI成人。

关键数值与推荐

  • 重点疾病包括归因于糖尿病或高血压的CKD以及归因于缺血性和毒性损伤的AKI。
  • 参照肾组织(如活体供肾活检)也将被评估。
  • 传统与数字病理结合转录组、蛋白组、代谢组分析及深度临床表型,用于监督与无监督亚组分析和系统生物学分析。
  • 受试者前瞻随访10年以明确临床结局。

临床怎么用

  • 项目数据将向科学家、临床医生和患者广泛开放使用。
  • 在健康与疾病状态下刻画细胞类型、位置和功能,并置于开放可检索的在线肾脏组织图谱中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic kidney disease (CKD) and acute kidney injury (AKI) are common, heterogeneous, and morbid diseases. Mechanistic characterization of CKD and AKI in patients may facilitate a precision-medicine approach to prevention, diagnosis, and treatment. The Kidney Precision Medicine Project aims to ethically and safely obtain kidney biopsies from participants with CKD or AKI, create a reference kidney atlas, and characterize disease subgroups to stratify patients based on molecular features of disease, clinical characteristics, and associated outcomes. An additional aim is to identify critical cells, pathways, and targets for novel therapies and preventive strategies. This project is a multicenter prospective cohort study of adults with CKD or AKI who undergo a protocol kidney biopsy for research purposes. This investigation focuses on kidney diseases that are most prevalent and therefore substantially burden the public health, including CKD attributed to diabetes or hypertension and AKI attributed to ischemic and toxic injuries. Reference kidney tissues (for example, living-donor kidney biopsies) will also be evaluated. Traditional and digital pathology will be combined with transcriptomic, proteomic, and metabolomic analysis of the kidney tissue as well as deep clinical phenotyping for supervised and unsupervised subgroup analysis and systems biology analysis. Participants will be followed prospectively for 10 years to ascertain clinical outcomes. Cell types, locations, and functions will be characterized in health and disease in an open, searchable, online kidney tissue atlas. All data from the Kidney Precision Medicine Project will be made readily available for broad use by scientists, clinicians, and patients.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. de Boer IH, Alpers CE, Azeloglu EU, et al. Rationale and design of the Kidney Precision Medicine Project. Kidney Int. 2021. PMID: 33637194. doi:10.1016/j.kint.2020.08.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。